Literature DB >> 29869115

Imaging studies in pediatric fibromuscular dysplasia (FMD): a single-center experience.

Robert Louis1,2, Daniella Levy-Erez3,4, Anne Marie Cahill2,5, Kevin E Meyers1,2.   

Abstract

BACKGROUND: Fibromuscular dysplasia (FMD) is a non-inflammatory vascular disease that in children unlike in adults shows no sex predilection. FMD is often underdiagnosed, and its pathophysiology is unclear. Delayed diagnosis may lead to refractory hypertension and decreases the chance of successful treatment. Doppler ultrasound (US), magnetic resonance angiography (MRA), computed tomography angiography (CTA), and catheter-based angiography (angiography) are currently used to help make a clinicoradiological diagnosis of FMD. The main aim of the study was to compare the efficacy of imaging modalities which can allow for earlier and improved detection. Furthermore, an anatomical mapping of the location of lesions can help determine the best treatment modalities.
METHODS: All patients with non-syndromic non-inflammatory renovascular hypertension were recruited from the Nephrology Department at the Children's Hospital of Philadelphia (CHOP) and enrolled in the U.S. FMD Registry maintained at the University of Michigan. Clinical presentation and imaging findings on US, CT, and MRI of children diagnosed with FMD were evaluated.
RESULTS: Mean age at diagnosis was 7 ± 4.9 years (4 months-17 years). Family history of hypertension (HTN) (52%), FMD (8.7%), Caucasian (60%), headache (48%), and HTN (80%) were the most prevalent symptom and sign at presentation. Bruits were 100% specific for renal artery stenosis (RAS) diagnosis but were heard in the minority of patients (3 patients, 12%). FMD was mainly unifocal within a single site (68%) or multiple sites (28%) and involved the main or first order renal branch in about 68% of children. Isolated distal lesions beyond the second order branches were found in about 25% of children. US imaging was significantly less sensitive than angiography (28%, p = 0.003). MRA had a better sensitivity (62.5%, p = 0.3) than US. Overall, CTA had the best sensitivity (84.2%, p = 0.4) compared to angiography; however, only angiography showed distal vessel disease.
CONCLUSIONS: Limitations of the study include the sample size and biases-only patients diagnosed with FMD were included in this study and most patients were referred to a pediatric nephrologist for unexplained hypertension. Angiography should be performed as part of the initial work-up of any child suspected of having renovascular FMD, regardless of the findings seen on US, MRA, or CTA.

Entities:  

Keywords:  Angiography; Fibromuscular dysplasia; Hypertension

Mesh:

Year:  2018        PMID: 29869115      PMCID: PMC6082421          DOI: 10.1007/s00467-018-3983-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  The role of CT angiography in the evaluation of pediatric renovascular hypertension.

Authors:  Jessica Kurian; Monica Epelman; Kassa Darge; Kevin Meyers; Els Nijs; Jeffrey C Hellinger
Journal:  Pediatr Radiol       Date:  2012-12-04

3.  A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis.

Authors:  H Eklöf; H Ahlström; A Magnusson; L-G Andersson; B Andrén; A Hägg; D Bergqvist; R Nyman
Journal:  Acta Radiol       Date:  2006-10       Impact factor: 1.990

Review 4.  Balancing Overscreening and Underdiagnosis in Secondary Hypertension: The Case of Fibromuscular Dysplasia.

Authors:  Marcel Ruzicka; Sarah E Kucharski; Swapnil Hiremath
Journal:  Cardiol Clin       Date:  2017-05       Impact factor: 2.213

5.  Evaluation of low-dose CT angiography with model-based iterative reconstruction after endovascular aneurysm repair of a thoracic or abdominal aortic aneurysm.

Authors:  Neil J Hansen; Ravi K Kaza; Katherine E Maturen; Peter S Liu; Joel F Platt
Journal:  AJR Am J Roentgenol       Date:  2014-03       Impact factor: 3.959

6.  Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates.

Authors:  Nicholas J Hendricks; Alan H Matsumoto; John F Angle; Aparna Baheti; Saher S Sabri; Auh W Park; James R Stone; James T Patrie; Lance Dworkin; Christopher J Cooper; Timothy P Murphy; Donald E Cutlip
Journal:  Vasc Med       Date:  2014-07-31       Impact factor: 3.239

Review 7.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

8.  Renovascular CT: comparison between adaptive statistical iterative reconstruction and model-based iterative reconstruction.

Authors:  Y Noda; S Goshima; H Koyasu; S Shigeyama; T Miyoshi; H Kawada; N Kawai; M Matsuo
Journal:  Clin Radiol       Date:  2017-06-30       Impact factor: 2.350

Review 9.  Multimodality imaging of fibromuscular dysplasia.

Authors:  Sara Lewis; Daniella Kadian-Dodov; A Bansal; R A Lookstein
Journal:  Abdom Radiol (NY)       Date:  2016-10

10.  PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance.

Authors:  Soto Romuald Kiando; Nathan R Tucker; Luis-Jaime Castro-Vega; Alexander Katz; Valentina D'Escamard; Cyrielle Tréard; Daniel Fraher; Juliette Albuisson; Daniella Kadian-Dodov; Zi Ye; Erin Austin; Min-Lee Yang; Kristina Hunker; Cristina Barlassina; Daniele Cusi; Pilar Galan; Jean-Philippe Empana; Xavier Jouven; Anne-Paule Gimenez-Roqueplo; Patrick Bruneval; Esther Soo Hyun Kim; Jeffrey W Olin; Heather L Gornik; Michel Azizi; Pierre-François Plouin; Patrick T Ellinor; Iftikhar J Kullo; David J Milan; Santhi K Ganesh; Pierre Boutouyrie; Jason C Kovacic; Xavier Jeunemaitre; Nabila Bouatia-Naji
Journal:  PLoS Genet       Date:  2016-10-28       Impact factor: 5.917

View more
  7 in total

Review 1.  Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS).

Authors:  Ramya Sivasubramanian; Kevin E Meyers
Journal:  Curr Hypertens Rep       Date:  2021-03-29       Impact factor: 5.369

2.  Clinical characteristics and long-term outcomes of endovascular treatment of renal artery fibromuscular dysplasia with branch lesions.

Authors:  Kun Li; Mingzhe Cui; Kewei Zhang; Kai Liang; Shuiting Zhai
Journal:  Pediatr Nephrol       Date:  2021-04-10       Impact factor: 3.714

Review 3.  Renovascular hypertension in pediatric patients: update on diagnosis and management.

Authors:  Juliana Lacerda de Oliveira Campos; Letícia Bitencourt; Ana Luisa Pedrosa; Diego Ferreira Silva; Filipe Ji Jen Lin; Lucas Teixeira de Oliveira Dias; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-04-13       Impact factor: 3.714

4.  Pediatric Renovascular Hypertension: The Diagnostic Algorithm.

Authors:  Divya Dhiman; Avinash Sharma
Journal:  Indian Pediatr       Date:  2020-11-15       Impact factor: 1.411

5.  Presentation, treatment, and outcome of renovascular hypertension below 2 years of age.

Authors:  Eda Didem Kurt-Sukur; Eileen Brennan; Meryl Davis; Colin Forman; George Hamilton; Nicos Kessaris; Stephen D Marks; Clare A McLaren; Kishore Minhas; Premal A Patel; Derek J Roebuck; Jelena Stojanovic; Sam Stuart; Kjell Tullus
Journal:  Eur J Pediatr       Date:  2022-07-06       Impact factor: 3.860

Review 6.  The complex genetic basis of fibromuscular dysplasia, a systemic arteriopathy associated with multiple forms of cardiovascular disease.

Authors:  Adrien Georges; Nabila Bouatia-Naji
Journal:  Clin Sci (Lond)       Date:  2022-08-31       Impact factor: 6.876

7.  Validation of computed tomography angiography as a complementary test in the assessment of renal artery stenosis: a comparison with digital subtraction angiography.

Authors:  Anilawan S Fleury; Rachelle E Durand; Anne Marie Cahill; Xiaowei Zhu; Kevin E Meyers; Hansel J Otero
Journal:  Pediatr Radiol       Date:  2021-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.